45 results
8-K
EX-99.1
SONX
Sonendo, Inc.
8 May 24
Sonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset Priorities
4:07pm
cost of sales
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
Total operating expenses
Operating loss …
Included in research and development
Depreciation and amortization
Included in cost of sales
Included in selling, general and administrative
Included
PRE 14A
SONX
Sonendo, Inc.
18 Apr 24
Preliminary proxy
4:17pm
was acquired by ATS Medical and later by Medtronic, Inc. At 3F Therapeutics, Inc., Mr. Bergheim was responsible for building the research and development … in or maintenance of such price or dividends); regulatory achievements or compliance; implementation, completion or attainment of objectives relating to research
8-K
EX-99.1
xo2yi4ahm0i
11 Mar 24
Sonendo Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Full Year 2024 Revenue Guidance
4:10pm
8-K
EX-99.1
5b0a5 mju9n0bxa
8 Nov 23
Sonendo, Inc. Reports Third Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
yt3tfdyw2vd3 carf
9 Aug 23
Sonendo, Inc. Reports Second Quarter 2023 Financial Results
4:10pm
8-K
EX-99.1
mf6bo7k07tlz49c37bbt
9 May 23
Sonendo, Inc. Reports First Quarter 2023 Financial Results
4:10pm
8-K
EX-99.1
endgafqs2l 099
9 Nov 22
Sonendo, Inc. Reports Third Quarter 2022 Financial Results
4:10pm
8-K
EX-10.2
m2j0373 4wlcbdzyvjs
23 Sep 22
Sonendo, Inc. Announces $63 Million Private Placement
7:00am
8-K
EX-10.1
pgwxkt8dbu1gya
23 Sep 22
Sonendo, Inc. Announces $63 Million Private Placement
7:00am
8-K
EX-99.1
y5i32yli05
10 Aug 22
Sonendo, Inc. Reports Second Quarter 2022 Financial Results
4:05pm